Companies: 10,795·Total market cap: $144.5T
Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE.CNCNQHealthcare● Active
$0.12
+$0.00(+0.00%)
Market Cap$22217770
P/E Ratio
52W High$0.18
52W Low$0.03
Overview

Lobe Sciences Ltd. (LOBE.CN) Revenue

Annual & quarterly revenue history · segment & region breakdown

LOBE.CN · revenue · updated Jun 10, 2026

Core revenue metrics

Lobe Sciences Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
0 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Lobe Sciences Ltd. SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
LOBE.CN revenue by year · LOBE.CN revenue history · LOBE.CN annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Lobe Sciences Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Lobe Sciences Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Lobe Sciences Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LOBE.CN revenue · 4 questions

LOBE.CN's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

LOBE.CN revenueLOBE.CN annual revenuewhat is LOBE.CN revenueLOBE.CN TTM revenue

Source: FMP · Lobe Sciences Ltd. SEC filings · GAAP · Lobe Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026